Brainsway Ltd (NASDAQ:BWAY) — Market Cap & Net Worth
Market Cap & Net Worth: Brainsway Ltd (BWAY)
Brainsway Ltd (NASDAQ:BWAY) has a market capitalization of $529.64 Million ($529.64 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #12248 globally and #2877 in its home market, demonstrating a 6.92% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Brainsway Ltd's stock price $16.84 by its total outstanding shares 40033028 (40.03 Million). Analyse Brainsway Ltd cash flow conversion to see how efficiently the company converts income to cash.
Brainsway Ltd Market Cap History: 2019 to 2026
Brainsway Ltd's market capitalization history from 2019 to 2026. Data shows growth from $390.32 Million to $674.16 Million (6.11% CAGR).
Index Memberships
Brainsway Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.02% | #315 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #1164 of 3165 |
Weight: Brainsway Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Brainsway Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Brainsway Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
14.47x
Brainsway Ltd's market cap is 14.47 times its annual revenue
Latest Price to Earnings (P/E) Ratio
98.97x
Brainsway Ltd's market cap is 98.97 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $390.32 Million | $23.10 Million | -$10.33 Million | 16.90x | N/A |
| 2020 | $301.85 Million | $22.06 Million | -$5.38 Million | 13.68x | N/A |
| 2021 | $308.25 Million | $29.66 Million | -$6.46 Million | 10.39x | N/A |
| 2022 | $98.88 Million | $27.18 Million | -$13.35 Million | 3.64x | N/A |
| 2023 | $259.41 Million | $31.79 Million | -$4.20 Million | 8.16x | N/A |
| 2024 | $377.51 Million | $41.02 Million | $2.92 Million | 9.20x | 129.24x |
| 2025 | $761.43 Million | $52.64 Million | $7.69 Million | 14.47x | 98.97x |
Competitor Companies of BWAY by Market Capitalization
Companies near Brainsway Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to Brainsway Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Brainsway Ltd Historical Marketcap From 2019 to 2026
Between 2019 and today, Brainsway Ltd's market cap moved from $390.32 Million to $ 674.16 Million, with a yearly change of 6.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $674.16 Million | -11.46% |
| 2025 | $761.43 Million | +101.70% |
| 2024 | $377.51 Million | +45.52% |
| 2023 | $259.41 Million | +162.35% |
| 2022 | $98.88 Million | -67.92% |
| 2021 | $308.25 Million | +2.12% |
| 2020 | $301.85 Million | -22.67% |
| 2019 | $390.32 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Brainsway Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $529.64 Million USD |
| MoneyControl | $529.64 Million USD |
| MarketWatch | $529.64 Million USD |
| marketcap.company | $529.64 Million USD |
| Reuters | $529.64 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, sc… Read more